Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

Brain Research

Volumn 1418, Issue , 2011, Pages 1-11

  Kania, Katarzyna D ^a,b   Wijesuriya, Hasini C ^a   Hladky, Stephen B ^a   Barrand, Margery A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Amyloid; ABCB1; ABCC4; ABCG2; Human brain endothelial cell; Wnt catenin signalling

Indexed keywords

AMYLOID BETA PROTEIN; BETA CATENIN; DICKKOPF 1 PROTEIN; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 4; WNT3A PROTEIN;

ARTICLE; BRAIN CELL; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ATP-BINDING CASSETTE TRANSPORTERS; BETA CATENIN; BIOLOGICAL TRANSPORT; BRAIN; CELL LINE, TRANSFORMED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEINS; RHODAMINE 123; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES; WNT PROTEINS;

EID: 80053386106     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.08.044     Document Type: Article

References (36)

1. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nature Rev. Neurosci. 7 2006 41 53 (Pubitemid 41828930)
2. J. Attems, H. Yamaguchi, T.C. Saido, and D.R. Thal Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology J. Neurol. Sci. 299 2010 155 162
3. S.A. Austin, M.A. Sens, and C.K. Combs Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells J. Neurosci. 29 2009 14451 14462
4. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol. 118 2009 103 113
5. A. Brenn, M. Grube, M. Peters, A. Fischer, G. Jedlitschky, H.K. Kroemer, R.W. Warzok, and S. Vogelgesang Beta-amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice Int. J. Alzheimers Dis. 2011 2011 10.4061/2011/690121
6. A. Caricasole, A. Copani, F. Caraci, E. Aronica, A.J. Rozemuller, A. Caruso, M. Storto, G. Gaviraghi, G.C. Terstappen, and F. Nicoletti Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain J. Neurosci. 24 2004 6021 6027 (Pubitemid 38859398)
7. A. Cedazo-Minguez, B.O. Popescu, J.M. Blanco-Millan, S. Akterin, J.-J. Pei, B. Winblad, and R.F. Cowburn Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β J. Neurochem. 87 2003 1152 1164 (Pubitemid 37492856)
8. J.R. Cirrito, R. Deane, A.M. Fagan, M.L. Spinner, M. Parsadanian, M.B. Finn, H. Jiang, J.L. Prior, A. Sagare, K.R. Bales, S.M. Paul, B.V. Zlokovic, D. Piwnica-Worms, and D.M. Holtzman P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model J. Clin. Invest. 115 2005 3285 3290 (Pubitemid 41567593)
9. H.C. Cooray, S. Shahi, A.P. Cahn, H.W. van Veen, S.B. Hladky, and M.A. Barrand Modulation of P-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids Eur. J. Pharmacol. 531 2006 25 31
10. K.N. Dahlgren, A.M. Manelli, W.B. Stine, L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053 (Pubitemid 34969015)
11. S. Dauchy, F. Miller, P.-O. Couraud, R.J. Weaver, B. Weksler, I.-A. Romero, J.-M. Scherrmann, I. de Waziers, and X. Decleves Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells Biochem. Pharmacol. 77 2009 897 909
12. G.V. De Ferrari, M.A. Chacon, M.I. Barria, J.L. Garrido, J.A. Godoy, G. Olivares, A.E. Reyes, A. Alvarez, M. Bronfman, and N.C. Inestrosa Activation of Wnt signalling rescues neurodegeneration and behavioural impairments induced by β-amyloid fibrils Mol. Psychiatry 8 2003 195 208 (Pubitemid 36315228)
13. R.A. Felix, and M.A. Barrand P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress J. Neurochem. 80 2002 64 72 (Pubitemid 34614578)
14. C. Giovanna, C. Cecchi, A. Pensalfini, S.A. Bonini, G. Ferrari-Toninelli, G. Liguri, M. Memo, and D. Uberti Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways Amino Acids 38 2010 1101 1106
15. F.J. Gonzales-Velasquez, J.A. Kotarek, and M.A. Moss Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers J. Neurochem. 107 2008 466 477
16. S.A. Gravina, L. Ho, C.B. Eckman, K.E. Long, L. Otvos Jr., L.H. Younkin, N. Suzuki, and S.G. Younkin Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43) J. Biol. Chem. 270 1995 7013 7016
17. D.R. Gustafson, I. Skoog, L. Rosengren, H. Zetterberg, and K. Blennow Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women J. Neurol. Neurosurg. Psychiatry 78 2007 461 464 (Pubitemid 46662891)
18. C. Hooper, R. Killick, and S. Lovestone The GSK3 hypothesis of Alzheimer's disease J. Neurochem. 104 2008 1433 1439 (Pubitemid 351316776)
19. H. Komekado, H. Yamamoto, T. Chiba, and A. Kikuchi Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt3a Genes Cells 12 2007 521 534 (Pubitemid 46488587)
20. S. Liebner, and K.H. Plate Differentiation of the brain vasculature: the answer came blowing by the Wnt J. Angiogen. Res. 2 2010 1 10
21. J.C. Lim, K.D. Kania, H. Wijesuriya, S. Chawla, J.K. Sethi, L. Pulaski, I.A. Romero, P.-O. Couraud, B.B. Weksler, S.B. Hladky, and M.A. Barrand Activation of β-catenin signalling by GSK-3 inhibition increases P-glycoprotein expression in brain endothelial cells J. Neurochem. 106 2008 1855 1865
22. R.-Q. Liu, Q.-H. Zhou, S.-R. Ji, Q. Zhou, D. Feng, Y. Wu, and S.-F. Sui Membrane localization of β-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization J. Biol. Chem. 285 2010 19986 19996
23. M.H. Magdesian, M.M.V.F. Carvalho, F.A. Mendes, L.M. Saraiva, M.A. Juliano, L. Juliano, J. Garcia-Abreu, and S.T. Ferreira Amyloid-β binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/β-catenin signalling J. Biol. Chem. 283 2008 9359 9368
24. D.S. Miller, B. Bauer, and A.M.S. Hartz Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy Pharmacol. Rev. 60 2008 196 209 (Pubitemid 351962009)
25. M. Pesaresi, C. Lovati, P. Bertora, E. Mailland, D. Galimberti, E. Scarpini, P. Quadri, G. Forloni, and C. Mariani Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment Neurobiol. Aging 27 2006 904 905 (Pubitemid 44287903)
26. S.J. Robertson, K.D. Kania, S.B. Hladky, and M.A. Barrand P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation J. Neurochem. 111 2009 132 141
27. L. Shabala, C. Howells, A.K. West, and R.S. Chung Prolonged Aβ treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca+ homeostasis Mol. Neurodegen. 5 2010 30
28. L.M. Tai, A.J. Loughlin, D.K. Male, and I.A. Romero P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta J. Cereb. Blood Flow Metab. 29 2009 1079 1083
29. L.M. Tai, P.S. Reddy, M.A. Lopez-Ramirez, H.A. Davies, D.K. Male, A.J. Loughlin, and I.A. Romero Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123 Brain Res. 1292 2009 14 24
30. L.M. Tai, K.A. Holloway, D.K. Male, A.J. Loughlin, and I.A. Romero Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation J. Cell. Mol. Med. 14 2010 1101 1112
31. S. Vogelgesang, I. Cascorbi, E. Schroeder, J. Pahnke, H.K. Kroemer, W. Siegmund, C. Kunert-Keil, L.C. Walker, and R.W. Warzok Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics 12 2002 535 541 (Pubitemid 35177083)
32. B.B. Weksler, E.A. Subileau, N. Perriere, P. Charneau, K. Holloway, M. Leveque, H. Tricoire-Leignel, A. Nicotra, S. Bourdoulous, P. Turowski, D.K. Male, F. Roux, J. Greenwood, I.A. Romero, and P.-O. Couraud Blood-brain barrier-specific properties of a human adult brain endothelial cell line FASEB J. 19 2005 1872 1874 (Pubitemid 41598779)
33. H.C. Wijesuriya, J.Y. Bullock, R.L.M. Faull, S.B. Hladky, and M.A. Barrand ABC efflux transporters in brain vasculature of Alzheimer's subjects Brain Res. 1358 2010 228 238
34. H. Xiong, D. Callaghan, A. Jones, J. Bai, I. Rasquinha, C. Smith, K. Pei, D. Walker, L.-F. Lue, D. Stanimirovic, and W. Zhang ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Aβ1-40 peptides J. Neurosci. 29 2009 5463 5475
35. Z. Zhang, J.-Y. Wu, W.N. Hait, and J.-M. Yang Regulation of the stability of P-glycoprotein by ubiquitination Mol. Pharmacol. 66 2004 395 403 (Pubitemid 39329238)
36. B. Zlokovic New therapeutic targets in the neurovascular pathway in Alzheimer's disease Neurotherap 5 2008 409 414 (Pubitemid 351952489)